319 related articles for article (PubMed ID: 33038939)
1. Cytokine Storms in Cancer and COVID-19.
Turnquist C; Ryan BM; Horikawa I; Harris BT; Harris CC
Cancer Cell; 2020 Nov; 38(5):598-601. PubMed ID: 33038939
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2: a storm is raging.
Pedersen SF; Ho YC
J Clin Invest; 2020 May; 130(5):2202-2205. PubMed ID: 32217834
[TBL] [Abstract][Full Text] [Related]
3. Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm.
Mahmoudi S; Rezaei M; Mansouri N; Marjani M; Mansouri D
J Clin Immunol; 2020 Oct; 40(7):974-976. PubMed ID: 32648027
[No Abstract] [Full Text] [Related]
4. Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.
Abid MB; Mughal M; Abid MA
JAMA Oncol; 2020 Oct; 6(10):1529-1530. PubMed ID: 32433719
[No Abstract] [Full Text] [Related]
5. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
[TBL] [Abstract][Full Text] [Related]
6. Working Hypothesis for Glucose Metabolism and SARS-CoV-2 Replication: Interplay Between the Hexosamine Pathway and Interferon RF5 Triggering Hyperinflammation. Role of BCG Vaccine?
Laviada-Molina HA; Leal-Berumen I; Rodriguez-Ayala E; Bastarrachea RA
Front Endocrinol (Lausanne); 2020; 11():514. PubMed ID: 32733388
[No Abstract] [Full Text] [Related]
7. Cellular immune responses to covid-19.
Sewell HF; Agius RM; Stewart M; Kendrick D
BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
[No Abstract] [Full Text] [Related]
8. Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19.
Liu T; Zeng G; Tao H; Shi Y; ; Wang T; Liu T; Guo F; Zhou F; Wang X
Int J Cancer; 2020 Dec; 147(11):3267-3269. PubMed ID: 32525566
[No Abstract] [Full Text] [Related]
9. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages.
Merad M; Martin JC
Nat Rev Immunol; 2020 Jun; 20(6):355-362. PubMed ID: 32376901
[TBL] [Abstract][Full Text] [Related]
10. Cytokine Storms: Understanding COVID-19.
Mangalmurti N; Hunter CA
Immunity; 2020 Jul; 53(1):19-25. PubMed ID: 32610079
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.
Wu Q; Chu Q; Zhang H; Yang B; He X; Zhong Y; Yuan X; Chua MLK; Xie C
Cancer Commun (Lond); 2020 Aug; 40(8):374-379. PubMed ID: 32666636
[No Abstract] [Full Text] [Related]
12. Defining the Cytokine Storm Syndrome of COVID-19: Role of the Clinical Laboratory.
Jialal I; Devaraj S
Ann Clin Lab Sci; 2020 Sep; 50(5):703-705. PubMed ID: 33067221
[No Abstract] [Full Text] [Related]
13. Long-term infection of SARS-CoV-2 changed the body's immune status.
Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
[TBL] [Abstract][Full Text] [Related]
14. COVID-19: consider cytokine storm syndromes and immunosuppression.
Mehta P; McAuley DF; Brown M; Sanchez E; Tattersall RS; Manson JJ;
Lancet; 2020 Mar; 395(10229):1033-1034. PubMed ID: 32192578
[No Abstract] [Full Text] [Related]
15. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 cytokine storm: the interplay between inflammation and coagulation.
Jose RJ; Manuel A
Lancet Respir Med; 2020 Jun; 8(6):e46-e47. PubMed ID: 32353251
[No Abstract] [Full Text] [Related]
17. Unraveling the Immune Response in Severe COVID-19.
Rodriguez L; Brodin P
J Clin Immunol; 2020 Oct; 40(7):958-959. PubMed ID: 32827284
[No Abstract] [Full Text] [Related]
18. When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection.
Damsky W; Peterson D; King B
J Am Acad Dermatol; 2020 Sep; 83(3):e269-e270. PubMed ID: 32565206
[No Abstract] [Full Text] [Related]
19. Molecular profiling of immune cell-enriched Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) interacting protein USP13.
Biterge Süt B
Life Sci; 2020 Oct; 258():118170. PubMed ID: 32735883
[TBL] [Abstract][Full Text] [Related]
20. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
Huizinga GP; Singer BH; Singer K
Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
